Packaged delivery of CRISPR–Cas9 ribonucleoproteins accelerates genome editing
Nucleic Acids Research · 27.02.2025 · 53 (5)
DOI: 10.1093/nar/gkaf105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 27.02.2025. Verfasst von Hannah Karp und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of California, Berkeley, CA 94720, United States. Hauptthemen laut MEDLINE: Ribonucleoproteins, Gene Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCRR NIH HHS, NIGMS NIH HHS, National Science Foundation.
Abstract (Originalsprache)
Effective genome editing requires a sufficient dose of CRISPR–Cas9 ribonucleoproteins (RNPs) to enter the target cell while minimizing immune responses, off-target editing, and cytotoxicity. Clinical use of Cas9 RNPs currently entails electroporation into cells ex vivo, but no systematic comparison of this method to packaged RNP delivery has been made. Here we compared two delivery strategies, electroporation and enveloped delivery vehicles (EDVs), to investigate the Cas9 dosage requirements for genome editing. Using fluorescence correlation spectroscopy, we determined that >1300 Cas9 RNPs per nucleus are typically required for productive genome editing. EDV-mediated editing was >30-fold more efficient than electroporation, and editing occurs at least 2-fold faster for EDV delivery at comparable total Cas9 RNP doses. We hypothesize that differences in efficacy between these methods result in part from the increased duration of RNP nuclear residence resulting from EDV delivery. Our results directly compare RNP delivery strategies, showing that packaged delivery could dramatically reduce the amount of CRISPR–Cas9 RNPs required for experimental or clinical genome editing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of California, Berkeley, CA 94720, United States.
- Innovative Genomics Institute, University of California, Berkeley, CA 94720, United States.
- Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, United States.
- California Institute for Quantitative Biosciences, University of California, Berkeley, CA 94720, United States.
- Gladstone Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA 94158, United States.
- ARC Institute, Palo Alto, CA 94304, United States.
ORCID-Profile: Jinna Brim, Alanna Schepartz, Jennifer A Doudna
Förderung
- NCRR NIH HHS
- NIGMS NIH HHS
- National Science Foundation
- Howard Hughes Medical Institute
- NIH HHS
- Emerson Collective
- Natural Sciences and Engineering Research Council of Canada
- National Institutes of Health
Zitieren
APA
Karp, H., Zoltek, M., Wasko, K., Vazquez, A. L., Brim, J., Ngo, W., Schepartz, A., & Doudna, J. A. (2025). Packaged delivery of CRISPR–Cas9 ribonucleoproteins accelerates genome editing. Nucleic Acids Research, 53(5). https://doi.org/10.1093/nar/gkaf105
Vancouver
Karp H, Zoltek M, Wasko K, Vazquez AL, Brim J, Ngo W, et al. Packaged delivery of CRISPR–Cas9 ribonucleoproteins accelerates genome editing. Nucleic Acids Research. 2025;53(5). doi:10.1093/nar/gkaf105
BibTeX
@article{Karp2025,
author = {Karp, Hannah and Zoltek, Madeline and Wasko, Kevin and Vazquez, Angel Luis and Brim, Jinna and Ngo, Wayne and Schepartz, Alanna and Doudna, Jennifer A},
title = {Packaged delivery of CRISPR–Cas9 ribonucleoproteins accelerates genome editing},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {5},
doi = {10.1093/nar/gkaf105}
}
EUVIMED